Diacylglycerol Signaling

98 J. Kim and D. Mochly-Rosen
Emanuel, S. L., Hughes, T. V., Adams, M., Rugg, C. A., Fuentes-Pesquera, A., Connolly, P. J.,
et al. (2008). Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB
kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial
tumors. Molecular Pharmacology, 73, 338–348.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., et al. (1995).
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. The
EMBO Journal, 14, 6148–6156.
Fields, A. P., Frederick, L. A., & Regala, R. P. (2007). Targeting the oncogenic protein kinase Ciota
signalling pathway for the treatment of cancer. Biochemical Society Transactions, 35, 996–1000.
Frey, M. R., Saxon, M. L., Zhao, X., Rollins, A., Evans, S. S., & Black, J. D. (1997). Protein
kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and
p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.
The Journal of Biological Chemistry, 272, 9424–9435.
Gavrielides, M. V., Frijhoff, A. F., Conti, C. J., & Kazanietz, M. G. (2004). Protein kinase C and
prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms. Current Drug
Targets, 5, 431–443.
Ghosh, S., Xie, W. Q., Quest, A. F., Mabrouk, G. M., Strum, J. C., & Bell, R. M. (1994). The
cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to
a segment that binds GTP-ras. The Journal of Biological Chemistry, 269, 10000–10007.
Gliki, G., Wheeler-Jones, C., & Zachary, I. (2002). Vascular endothelial growth factor induces protein
kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3’-kinase-mediates PKC
delta phosphorylation: Role of PKC in angiogenesis. Cell Biology International, 26, 751–759.
Gokmen-Polar, Y., & Fields, A. P. (1998). Mapping of a molecular determinant for protein kinase
C betaII isozyme function. The Journal of Biological Chemistry, 273, 20261–20266.
Graff, J. R., et al. (2005). The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.
HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth
of human colon cancer and glioblastoma xenografts. Cancer Research, 65, 7462–7469.
Griner, E. M., & Kazanietz, M. G. (2007). Protein kinase C and other diacylglycerol effectors in
cancer. Nature Reviews. Cancer, 7, 281–294.
Grossoni, V. C., Falbo, K. B., Kazanietz, M. G., de Kier Joffe, E. D., & Urtreger, A. J. (2007). Protein
kinase C delta enhances proliferation and survival of murine mammary cells. Molecular
Carcinogenesis, 46, 381–390.
Hernandez, A. I., Blace, N., Crary, J. F., Serrano, P. A., Leitges, M., Libien, J. M., et al. (2003).
Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase
C zeta catalytic domain. Implications for the molecular mechanism of memory. The Journal
of Biological Chemistry, 278, 40305–40316.
House, C., & Kemp, B. E. (1987). Protein kinase C contains a pseudosubstrate prototope in its
regulatory domain. Science, 238, 1726–1728.
House, C., Robinson, P. J., & Kemp, B. E. (1989). A synthetic peptide analog of the putative
substrate-binding motif activates protein kinase C. FEBS Letters, 249, 243–247.
Huang, H. C., Huang, C. Y., Lin-Shiau, S. Y., & Lin, J. K. (2009). Ursolic acid inhibits IL-1beta or
TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKCzeta
and downregulating the MMP-9 expression. Molecular Carcinogenesis, 48, 517–531.
Humphries, M. J., Limesand, K. H., Schneider, J. C., Nakayama, K. I., Anderson, S. M., &
Reyland, M. E. (2006). Suppression of apoptosis in the protein kinase Cdelta null mouse
in vivo. The Journal of Biological Chemistry, 281, 9728–9737.
Hurley, J. H., & Meyer, T. (2001). Subcellular targeting by membrane lipids. Current Opinion in
Cell Biology, 13, 146–152.
Inagaki, K., & Mochly-Rosen, D. (2005). DeltaPKC-mediated activation of epsilonPKC in ethanolinduced
cardiac protection from ischemia. Journal of Molecular and Cellular Cardiology, 39,
203–211.
Inagaki, K., Chen, L., Ikeno, F., Lee, F. H., Imahashi, K., Bouley, D. M., et al. (2003a). Inhibition
of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo.
Circulation, 108, 2304–2307.